Rukshana and lekhana therapy in Non alcoholic fatty liver disease

Evaluating the effectiveness of the principle of rukshana and lekhana in the management of non alcoholic fatty liver disease - NIL

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086912

Enrollment

Registered

2025-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients exhibiting clinical signs and symptoms of non-alcoholic fatty liver or yakrithodhara. Patients eligible for rukshana, Sneha virechana, and vasthi treatments. Patients aged between 20 to 60 years, of either gender. Patients with radiological evidence of Non-alcoholic fatty liver disease. Patients willing to provide informed consent. Patients with grade1,grade2 and grade3 fatty liver.

Exclusion criteria

Exclusion criteria: Individuals contraindicated for rukshana, Sneha virechana, and vasthi treatments. Pregnant and lactating women. Alcoholic liver disease. Fibrotic and cirrhotic liver conditions. Patients with cholecystitis and cholelithiasis Patients with grade4 fatty liver. Patients positive for HIV or HBsAg.

Design outcomes

Primary

Measure	Time frame
Lipid profile changes and weight reductionTimepoint: 30 days	—

Secondary

Measure	Time frame
changes in liver size, fatigue and abdominal discomfortTimepoint: 45 days	—

Countries

India

Contacts

Public ContactDr B johar

Dr BrKr Goverment ayurvedic medical college ,Erragada Hyderabad

joharburra1980@gmail.com9848923905

Outcome results